Glass’in®, specialist in the traceability of glass packaging, protects your goods in production by using a grafting process invisible to the naked eye and easily re-read on a production line.


Athéor is dedicated to working with companies in the development and implementation of complete unit tracking strategies, both for production monitoring and product identification and authentication.

The Athéor team has been involved in a number of traceability projects which have provided them with extensive experience and expertise.

Athéor offers a wide variety of services from step by step project exposition, system implementation, user training, and maintenance work.

Athéor also provides the best mechanical expertise, ensuring the most thoughtful and precise installation possible.

Athéor combines the industry skill and product expertise necessary to understand your needs and ensure the success of your project.

Athéor offers installation on site to ensure the best possible tracking and security for clients with high risk product.

All systems are set up to create custom processes adaptable to both linear and rotary machinery.

With its chemical advancements, Athéor can offer custom sol-gel inks, adaptable to your specific needs.


According to the National Anti-counterfeiting Center, the legal definition of counterfeiting is as follows: “Counterfeiting is the imitation, use, and total or partial reproduction of a trademark, design, model, patent, software, copyright, or plant variety without authorization from the proprietor”. Regarding the pharmaceutical sector, it should be noted that the word “counterfeit” is used synonymously with “falsified”.
The National Department of Health and Medicine (ANSM, France) covers three types of products: counterfeit products, reproductions of unauthorized drugs, and falsified products considered a medical drug based on composition and/or appearance but are not labeled.

This last type of product covered by ANSM is a pharmaceutical specialty. Whether brand name or generic, these are drugs that are not reviewed by the health administration for evaluation and inspection and are then sold outside the mainstream legal market. These types of counterfeit drugs are often sold online.

The pharmaceutical industry is doing its part to find a solution. According to the World Health Organization, the circumstances are alarming. Nearly 10% of all drugs available for sale on the global market are counterfeit.


Traceability strengthens four main elements: identification, authenticity, location, and security.
The weight of each of these sectors is what determines all technological and structural advancements.
According to standard ISO 8402, traceability is defined as the ability to recover the history or location of an item or activity…by means of registered identification. It’s being able to locate an object or component at any time during the production or distribution process, and then retroactively reset the course of each object.

Let’s not forget that traceability is also an effective means of fighting counterfeiting, fraud, forgery, and the diversion of commercial markets, known as parallel or black markets.

France is the main victim. Other European countries such as Germany and England buy large quantities of drugs through French platforms to resell them at a higher price through their own market.

These practices destabilize the market and create shortages of product. The traceability market is booming with annual growth of +15% over the past 4 years and is expected to continue to grow in the years to come. Medication must be safe, stable, and effective throughout the duration of its lifecycle until the very last step: patient intake.

It is with the patient’s protection and well-being in mind that pharmaceutical industries ensure their drugs’ safety and quality during production and on the market.

To ensure this, a safety management system was founded and required by the GMP (Good Manufacturing Practice), the fundamental production reference for the pharmaceutical industry.

Cross contamination is the contamination of one product by another. This can have extreme altering effects on the quality of a medication and must therefore be properly managed. Cross contamination can happen at any stage of the production process, making it a critical and challenging problem for pharmaceutical companies to face.

Unit traceability is essential for identifying products that don’t meet GMP standards. Batch traceability forces manufacturers to destroy entire lots of product even if only a portion are faulty. This creates considerable financial loss and damages.


Thanks to their innovative glass grafting technique, Athéor® is the expert in unit traceability and authentication

contact details

399 rue Georges Séguy

34080 Montpellier

Tél. : 04 48 79 07 59

Mail : info(@)atheor(.)com

contact us

Athéor S.A.S

41 Rue Yves Montand
34080 Montpellier